Dr.Long Pang |Oncology Pharmaceuticals| Best Researcher Award-1332

Published on by Top Pharmaceutical

Dr.Long Pang|Oncology Pharmaceuticals |Best Researcher Award|

Dr.Long Pang at Xi’an Medical University, China

PROFILE  

scopus

Early Academic Pursuits 📚

Long Pang was born in Gansu, China, where he developed an early passion for science and innovation. His academic journey began with a focus on veterinary science, where he pursued a Master of Science (M.S.) degree at Northwest Agricultural and Forestry University in Yangling, Shaanxi, China. Completing his M.S. in July 2012, Pang demonstrated an exceptional commitment to his studies and research in veterinary science, laying the groundwork for his future endeavors in animal biotechnology. In August 2012, he advanced his academic career by enrolling in a Ph.D. program at the same university. During his Ph.D. studies, he specialized in Animal Biotechnology, a field that encompasses the use of biotechnological tools for the improvement of animal health and productivity. He completed his Ph.D. in July 2016, marking the beginning of a promising career in biomedical research.

Professional Endeavors 🏢

After earning his Ph.D., Long Pang joined Xi’an Medical University as an Associate Professor in the School of Basic Medical Science. His professional career is distinguished by his innovative research in the areas of microfluidics and single-cell analysis. At Xi’an Medical University, Pang quickly established himself as a leading researcher, focusing on the development of microfluidic chips and their applications in single-cell analysis and organ-on-a-chip technology. His work has been instrumental in advancing the understanding of cellular mechanics and tumor microenvironments, contributing significantly to the fields of biomedical engineering and cancer research.

Contributions and Research Focus 🔬

Long Pang’s research primarily revolves around microfluidics-based single-cell analysis and organ-on-a-chip technologies. His work has led to the development of innovative microfluidic devices that allow for the manipulation and analysis of single cells in a highly controlled environment. These devices have broad applications in cancer research, particularly in studying tumor microenvironments and the behavior of cancer stem cells. One of his significant contributions includes the development of a microfluidic chip for glioma stem cell sorting and single-cell-derived tumor sphere assays. This research has provided valuable insights into the formation of tumor spheres and the role of the tumor microenvironment in cancer progression.

Pang has also been involved in projects aimed at integrating microfluidic platforms with other technologies to enhance the precision and efficiency of single-cell analysis. His research has been supported by several prestigious grants, including those from the National Science Foundation of China and the Fundamental Research Foundation of Xi’an Medical University. Notably, he has led projects such as the study of heterotypic single-cell-derived tumor-sphere formation using an integrated microfluidics platform, which has garnered significant attention and funding.

Accolades and Recognition 🏆

Long Pang’s contributions to the field of biomedical research have been widely recognized. His work has resulted in over 21 publications in high-impact journals, including TRAC-Trends in Analytical Chemistry, Analytical Chemistry, and Sensors & Actuators B: Chemical. He has also authored a chapter in the Handbook of Single-Cell Technologies, published by Springer, highlighting his expertise in digital microfluidics for single-cell manipulation and analysis. In addition to his publications, Pang has been granted two Chinese patents related to his innovations in microfluidic technology, further establishing his reputation as a leading researcher in his field.

Pang’s achievements have also been acknowledged through various editorial appointments. He has served as a Youth Editorial Board Member of Glioma and the E-Journal of Translational Medicine, where he has contributed to the advancement of research dissemination and knowledge sharing in the scientific community. His contributions to the academic community extend beyond research, as he is an active member of several professional organizations, including the Shaanxi Pharmacology Association, the Chinese Society of Micro-Nano Technology (CSMNT), and the Chinese Chemistry Society (CCS).

Impact and Influence 🌍

The impact of Long Pang’s research extends beyond academia. His work on microfluidic devices has the potential to revolutionize the way single-cell analysis is conducted, offering new tools for researchers and clinicians in the diagnosis and treatment of diseases, particularly cancer. His contributions to the development of organ-on-a-chip technology are also significant, providing a platform for more accurate and efficient drug testing, which could lead to more effective treatments for various diseases.

Pang’s research has influenced a new generation of scientists and engineers, inspiring them to explore the possibilities of microfluidics and its applications in biomedical research. His collaborations with other leading researchers and institutions, both in China and internationally, have further expanded the reach of his work, fostering innovation and knowledge exchange in the global scientific community.

Legacy and Future Contributions 🚀

Long Pang’s legacy in the field of biomedical research is characterized by his innovative approach to solving complex problems in cell biology and medicine. His contributions to the development of microfluidic technology and single-cell analysis tools have set new standards in the field, paving the way for future research and innovation. As he continues his work at Xi’an Medical University, Pang remains committed to advancing the frontiers of biomedical engineering, with a focus on developing new technologies that can improve human health and well-being.

Looking to the future, Long Pang’s ongoing research projects, such as the construction of a 3D microenvironment for single-cell level tumor cells, promise to yield further breakthroughs in our understanding of cancer and other diseases. His work is likely to continue to influence the field for years to come, as he mentors the next generation of researchers and contributes to the global effort to improve healthcare through technological innovation.

🎓Publication 

Tumor microenvironment-derived exosomes-assisted single-cell-derived tumor-sphere formation and drug-resistance by a microfluidic system

Construction of multiple concentration gradients for single-cell level drug screening

Droplets microfluidics platform—A tool for single cell research

Microfluidics-Based Single-Cell Research for Intercellular Interaction

Digital Microfluidics for Single Cell Manipulation and Analysis

  • Authors   :Pang, L., Ding, J., Fan, S.-K.
  • Journal    :Handbook of Single-Cell Technologies
  • Year         :2021

Prof. Fatma YURT|pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Fatma YURT |pharmaceuticals|Best Researcher Award|

Prof. Fatma YURT atEge University,Turkey

PROFILE  

scopus

Orcid

Early Academic Pursuits 🎓

Prof. Dr. Fatma Yurt’s journey into the scientific world began at Ege University, one of Turkey’s leading institutions. She completed her undergraduate studies at the Faculty of Science in the Department of Chemistry between 1982 and 1987. Her passion for science and dedication to learning set the stage for her illustrious career in nuclear sciences. Following her bachelor’s degree, she pursued a doctorate at Ege University in the Institute of Nuclear Sciences, specializing in Nuclear Sciences. From 1991 to 1998, she immersed herself in the study of nuclear applications, gaining a deep understanding of the field’s complexities and potential. This period of intense academic focus and research laid a solid foundation for her future contributions to nuclear medicine, radiopharmacy, and related fields.

Professional Endeavors 💼

Prof. Dr. Fatma Yurt’s professional career is marked by her steady rise through the academic ranks at Ege University. She began her career as a Research Assistant in the Nuclear Applications Department of the Institute of Nuclear Sciences, where she served from 1994 to 1997. This role allowed her to engage in cutting-edge research and contribute to the development of nuclear sciences in Turkey.

In 1999, she was promoted to Assistant Professor, and later in the same year, she achieved the rank of Associate Professor. Her commitment to education and research was evident as she continued to mentor students and lead research projects in nuclear applications. By 2007, she had earned the title of Professor, solidifying her position as a leading expert in her field.

Prof. Dr. Yurt’s expertise is not limited to academia; she has also held significant administrative roles. Since 2016, she has served as the Director of the Institute of Nuclear Sciences at Ege University. In this capacity, she has been instrumental in shaping the direction of nuclear research and education in Turkey, overseeing various projects and initiatives that have expanded the institute’s influence both nationally and internationally.

Contributions and Research Focus 🔬

Prof. Dr. Fatma Yurt’s research spans several critical areas within nuclear sciences, with a particular emphasis on nuclear medicine, radiopharmacy, and pharmacology. Her work in these fields has been pivotal in advancing the understanding and application of nuclear techniques in medicine, particularly in diagnosing and treating various diseases.

Her research contributions include the development of novel radiopharmaceuticals, which are essential for diagnosing and treating conditions such as cancer. Prof. Dr. Yurt’s expertise in nuclear chemistry and physical chemistry has enabled her to explore the intricate processes involved in the synthesis and application of these compounds. She has also contributed significantly to the field of health sciences, particularly in the areas of internal medicine and pharmaceutical technology.

With a Scopus publication count of 123 and a Unisis publication count of 296, Prof. Dr. Yurt’s research output is impressive. Her work has been cited over 1,447 times on Scopus, reflecting the impact and relevance of her research. Her H-Index, a measure of both the productivity and citation impact of her publications, stands at 21 on Scopus, further underscoring her influence in the field.

Accolades and Recognition 🏆

Throughout her career, Prof. Dr. Fatma Yurt has received numerous accolades and recognition for her contributions to nuclear sciences and medicine. Her research has been widely acknowledged by her peers, and she has been invited to present her findings at various national and international conferences. Her role as the Director of the Institute of Nuclear Sciences is a testament to her leadership abilities and her dedication to advancing the field of nuclear applications.

Prof. Dr. Yurt’s work has not only advanced scientific understanding but has also had a tangible impact on healthcare. Her contributions to radiopharmacy have been particularly significant, with her research playing a crucial role in the development of new diagnostic and therapeutic methods. Her dedication to her field is further demonstrated by her ongoing involvement in academic mentorship, helping to train the next generation of scientists in nuclear sciences.

Impact and Influence 🌍

Prof. Dr. Yurt’s influence extends beyond her research and academic roles. As a leader in nuclear sciences, she has been instrumental in promoting the importance of nuclear applications in medicine and other fields. Her work has helped to bridge the gap between basic research and practical applications, ensuring that the benefits of nuclear science are realized in clinical settings.

Her leadership at the Institute of Nuclear Sciences has also been pivotal in shaping the research agenda in Turkey, encouraging interdisciplinary collaboration and fostering a culture of innovation. Under her guidance, the institute has strengthened its position as a center of excellence in nuclear research, attracting students and researchers from around the world.

Legacy and Future Contributions 🌟

Prof. Dr. Fatma Yurt’s legacy is one of dedication, innovation, and leadership. Her contributions to nuclear medicine, radiopharmacy, and related fields have had a lasting impact on both the scientific community and the broader healthcare sector. As she continues her work, her influence will undoubtedly grow, inspiring new research and leading to further advancements in nuclear applications.

🎓Publication 

An in vitro evaluation of Hypericum perforatum loaded-chitosan nanoparticle/agarose film as a Wound dressing

Unveiling combat strategies against Candida spp. biofilm structures: Demonstration of photodynamic inactivation with innovative phthalocyanine derivatives

Platinum (II) Schiff Base Complexes and their Effects on the Inhibition of Amyloid β1–42 Aggregation

In Vitro Assessment of 177Lu-Labeled Trastuzumab-Targeted Mesoporous Carbon@Silica Nanostructure for the Treatment of HER2-Positive Breast Cancer

  • Authors   :Tunçel, A., Maschauer, S., Prante, O., Yurt, F.
  • Journal    :Pharmaceuticals
  • Year         :2024

 

Ms. Faezeh Aghajannataj Ahangarkola|Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Faezeh Aghajannataj Ahangarkola |Drug Delivery Systems|Best Researcher Award|

Ms. Faezeh Aghajannataj Ahangarkola at Babol Noshirvani University of Technology,Iran

PROFILE  

Google scholar

 

Early Academic Pursuits 🎓

Faezeh Aghajannataj began her academic journey with a strong foundation in pure chemistry, earning a Bachelor of Science degree from the University of Mazandaran (UMZ) in Babolsar, Iran, in September 2018. Her undergraduate studies focused on the synthesis of pharmaceutical heterocyclics, particularly through multi-component reactions. Under the guidance of Dr. Robabeh Baharfar, Faezeh’s final project received a stellar grade of 4.0/4.0, demonstrating her early aptitude for research and her keen interest in the intersection of chemistry and pharmaceuticals.

Building on her success at UMZ, Faezeh pursued a Master of Science degree in Biotechnology at the Babol Noshirvani University of Technology (BNUT), Babol, Iran. Her graduate research centered on the development of enteric hard capsules for targeting the small intestine, utilizing innovative materials like Pullulan and Eudragit L-100. This research culminated in a thesis titled “Enteric Hard Capsules for Targeting Small Intestine by Pullulan and Eudragit L-100: Processing, Characterization, and In-vitro Drug Release,” which was awarded a perfect grade of 4.0/4.0 (19/20), reflecting the high quality and significance of her work under the mentorship of Dr. Ghasem Najafpour.

Professional Endeavors 🏢

Faezeh’s professional career is marked by a strong focus on research and development in the pharmaceutical and biotechnology industries. During her time at Iran Gelatin Capsule in Tehran, she played a pivotal role as a member of the R&D team from February 2022 to May 2023. Her work primarily involved researching and formulating pullulan capsules at an industrial scale, a task that required both technical expertise and innovative thinking. Additionally, she contributed to the formulation and evaluation of controlled release systems designed to produce enteric-coated capsules without synthetic materials or external coatings, a project that aligns with the growing demand for more natural and sustainable pharmaceutical solutions.

Faezeh also gained significant experience as a teaching assistant during her academic career. She assisted in courses such as Organic Chemistry Laboratory and Physical Chemistry Laboratory at UMZ, and Advanced Engineering Mathematics at BNUT, showcasing her ability to convey complex scientific concepts to students. Her teaching roles not only enriched her understanding of the subjects but also allowed her to contribute to the academic growth of her peers.

Contributions and Research Focus 🔬

Faezeh’s research interests lie at the crossroads of biotechnology, pharmaceutical sciences, and chemistry. Her master’s thesis on enteric hard capsules represents a significant contribution to the field of drug delivery systems, particularly in the development of targeted delivery mechanisms for the small intestine. This work, which involved detailed processing, characterization, and in-vitro drug release studies, has the potential to impact the way oral medications are formulated and administered, particularly in terms of improving drug efficacy and patient outcomes.

Her research has been recognized through the publication of her work in reputable scientific journals. One notable publication is “Towards a Novel Pullulan and Pullulan-Enteric Hard Capsules: Study of Drug Release and Crucial Capsule Features,” co-authored with Dr. Gh. Najafpour and R. Ramezani. This paper, accessible , highlights the innovative approach Faezeh has taken in her research, contributing valuable knowledge to the field of drug delivery systems.

Accolades and Recognition 🏆

Throughout her academic and professional career, Faezeh has consistently achieved high marks and recognition for her work. Her thesis was awarded a perfect grade, reflecting the high esteem in which her research is held. Additionally, her academic achievements during her bachelor’s and master’s studies are underscored by her strong GPA, which stands at 3.6/4.0 (16.95/20) for her master’s degree, and her consistently high grades in her coursework.

Her work has also been recognized within the academic community through her roles as a teaching assistant, where she earned the trust of her professors to guide and mentor students in complex scientific subjects.

Impact and Influence 🌍

Faezeh’s research on drug delivery systems, particularly her focus on enteric capsules, has the potential to significantly impact the pharmaceutical industry. By developing more effective and targeted drug delivery mechanisms, her work could lead to improved patient outcomes, particularly for those with conditions that require precise delivery of medication to the small intestine.

Her influence extends beyond her research, as her roles as a teaching assistant and R&D member have allowed her to mentor and collaborate with others in the field, spreading her knowledge and fostering innovation in both academic and industrial settings.

Legacy and Future Contributions 🌟

Faezeh Aghajannataj is poised to make lasting contributions to the fields of biotechnology and pharmaceutical sciences. Her innovative approach to drug delivery systems and her commitment to research excellence set her apart as a leading figure in her field. As she continues her career, her work is likely to inspire future research and development in the industry, particularly in the creation of more sustainable and effective pharmaceutical solutions.

🎓Publication 

Ethanol fermentation in an immobilized cell reactor using Saccharomyces cerevisiae

  • Authors   :Ghasem Najafpour, Habibollah Younesi, Ku Syahidah Ku Ismail
  • Journal    :Bioresource technology
  • Year         :2024

Piperine—the bioactive compound of black pepper: from isolation to medicinal formulations

  • Authors   :Leila Gorgani, Maedeh Mohammadi, Ghasem D Najafpour, Maryam Nikzad
  • Journal    :Comprehensive reviews in food science and food safety
  • Year         :2017

High-rate anaerobic digestion of palm oil mill effluent in an upflow anaerobic sludge-fixed film bioreactor

  • Authors   :GD Najafpour, AAL Zinatizadeh, AR Mohamed, M Hasnain Isa, H Nasrollahzadeh
  • Journal    :Process Biochemistry
  • Year         :2006

Treatment of pulp and paper mill wastewater by polyacrylamide (PAM) in polymer induced flocculation

  • Authors   :SS Wong, TT Teng, AL Ahmad, A Zuhairi, G Najafpour
  • Journal    :Journal of hazardous materials
  • Year         :2006

Power generation from organic substrate in batch and continuous flow microbial fuel cell operations

  • Authors   :Mostafa Rahimnejad, Ali Asghar Ghoreyshi, Ghasem Najafpour, Tahereh Jafary
  • Journal    :Applied Energy
  • Year         :2011

Prof.Aleksandr Urakov|Drug Repurposing | Best Researcher Award

Published on by Top Pharmaceutical

Prof.Aleksandr Urakov, Drug Repurposing ,Best Researcher Award

Prof.Aleksandr Urakov atIzhevsk State Medical Academy,Russia

PROFILE  

scopus

Orcid

Academic Leadership 🏫

Professor Aleksandr Urakov serves as the head of the Department of General and Clinical Pharmacology at Izhevsk State Medical Academy. His leadership has been instrumental in shaping the department into a center of excellence in pharmacological research and education.

Innovative Contributions 🧠

As an inventor, Professor Urakov holds over 270 patents and has published more than 200 scientific articles . His research in temperature pharmacology and drug repurposing  has led to significant advancements, including the development of the floating tablet and warm alkaline hydrogen peroxide solutions .

Recognition and Honors 🎖️

For his remarkable contributions, Professor Urakov has been awarded the Order of the Badge of Honor and holds the prestigious title of Honored Inventor of the Russian Federation . His work continues to influence and inspire the medical community globally.

Research and Innovations🔬 :

Professor Urakov invented the floating tablet and discovered warm alkaline hydrogen peroxide solutions (WAHPSs), which include new drug subgroups like bruise bleaches, pus-dissolving drugs (pyolytics), and oxygen-producing antihypoxants. These innovations offer alternatives to ECMO for hypoxemia in COVID-19 asphyxia.

🎓Publication 

Comment: Balanced Salt Solutions for Critically Ill Patients: Nonplused and Back to Basics

Thermal imaging of local skin temperature as part of quality and safety assessment of injectable drugs

    • Authors :Urakov, A., Urakova, N., Samorodov, A., … Suntsova, D., Muhutdinov, N..
    • Journal   :Heliyon
    • Year       : 2024

Understanding burn injuries in children – A step toward prevention and prompt first aid

  • Authors  :Urakov, A.L., Suntsova, D.O., Yagudin, I.I.
  • Journal    :Burns
  • Year         :  2023

ASSESSMENT OF FETAL RESISTANCE TO HYPOXIA USING THE STANGE TEST AS AN ADJUNCT TO APGAR SCALE ASSESSMENT OF NEONATAL HEALTH STATUS

  • Authors  :Shabanov, P.D., Urakov, A.L., Urakova, N.A.
  • Journal   :Medicinskij Akademiceskij Zurnal,
  • Year        :   2023

Prospects for the pharmacological validation of the use of platelets as a “peripheral model” of neurons

Assoc Prof Dr.Guanyu Chen|Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Assoc Prof Dr.Guanyu Chen, Drug Delivery Systems,Best Researcher Award

Assoc Prof Dr.Guanyu Chen, at Sun Yat-Sen University School of Pharmaceutical Sciences Shenzhen,China

PROFILE  

scopus

🧪 Research Focus :

Associate Prof. Guanyu Chen is an expert in Drug Delivery and Immunochemotherapy at the School of Pharmaceutical Sciences, Sun Yat-sen University.

🎓 Education and Professional Experience :

He earned his Bachelor’s (2005-2008), Master’s (2009-2012), and PhD (2012-2016) degrees from the University of Auckland, New Zealand. Following his PhD, he worked as a Postdoctoral Fellow at the same university from 2017 to 2019. During this time, he also served as a Research Assistant at Ancare Scientific Ltd, Douglas Ltd, Alleva Animal Health Ltd, and Kimberly Clack Ltd. In 2019, he joined Sun Yat-sen University, China, as an Associate Professor.

💰 Research Funding :

Prof. Chen has received significant funding for his research, including the National Natural Science Foundation of China in 2022 (82273871), the Guangdong Basic and Applied Basic Research Foundation in 2021 (2021A1515110006), the Shenzhen Science and Technology Program in 2020 (GXWD20201231165807008), the 67th Batch Postdoc Research Foundation of China in 2019 (2020M673030), and the Kimberly Clarks Pharmaceutics Research Fund, USA in 2016 (32715.001).

🏅 Patents and Awards :

His achievements include two national invention patents and several prestigious awards: Overseas Senior Talent of Shenzhen, Recruiting Outstanding Overseas Talent of Guangdong, Maurice and Phyllis Paykel Research Award, Academic Career Exploration Scholarship, Edna and Denis Moloney Scholarship, FMHS-PGSA Award from the University of Auckland, Elite Editing Thesis Write-up Scholarship from Australia, and The University of Auckland Partnership Appeal Award.

📚 Editorial Roles :

Prof. Chen contributes to the academic community as a Youth Editorial Board Member for Acta Materia Medica and the Journal of Drug Delivery and Translational Research. He also serves as a Guest Editor for the Journal of Current Drug Delivery and Pharmaceutics.

🔍 Conclusion

Associate Prof. Guanyu Chen stands out as a leading researcher in drug delivery and immunochemotherapy, with a robust academic background and extensive experience. His significant contributions to the field are supported by notable research funding and a series of prestigious awards. As a dedicated academic and editorial contributor, Prof. Chen continues to advance pharmaceutical sciences through his research, mentorship, and publication efforts.

🎓Publication 

The scaffold protein AXIN1: gene ontology, signal network, and physiological function

Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis

Cryo-Milled β-Glucan Nanoparticles for Oral Drug Delivery

  • Authors  :Chen, G., Liu, Y., Svirskis, D., … Lu, W., Wen, J.
  • Journal    :Pharmaceutics
  • Year         :  2024

Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy

Development of a novel peptide targeting GPR81 to suppress adipocyte-mediated tumor progression

  • Authors  :Chen, S., Zhou, X., Li, W., … Liu, J., Gao, Y.
  • Journal   :Biochemical Pharmacology
  • Year        :  2023

Dr. Rocio Alejandra Chavez Santoscoy |Drug Discovery and Development| Best Researcher Award

Published on by Top Pharmaceutical

Dr. Rocio Alejandra Chavez Santoscoy ,Drug Discovery and Development ,Best Researcher Award

Dr. Rocio Alejandra Chavez Santoscoy, at Tecnológico de Monterrey,Mexico

PROFILES

scopus
Orcid

 

📚Early Academic Pursuits :

The foundation of the research on Bacillus clausii and its novel delivery systems traces back to early academic pursuits in microbiology and biotechnology. Researchers embarked on this journey by gaining extensive knowledge in microbial physiology, genetics, and the complex interactions between probiotics and the human gut microbiome. This academic groundwork was crucial in understanding the significance of Bacillus clausii as a robust probiotic strain capable of withstanding harsh gastrointestinal conditions.

🧪Professional Endeavors :

Professional endeavors in this field have seen a significant focus on the development and optimization of microencapsulation techniques. Scientists and researchers dedicated their efforts to creating advanced delivery systems that protect probiotics from the acidic environment of the stomach and ensure their controlled release in the intestines. This involved interdisciplinary collaborations between microbiologists, food scientists, and biotechnologists, who worked together to design and test various non-digestible carbohydrate formulations. These endeavors were aimed at enhancing the stability, viability, and efficacy of Bacillus clausii in probiotic supplements and functional foods.

🔬Contributions and Research Focus :

The primary research focus has been on the microencapsulation and controlled release of Bacillus clausii using a novel non-digestible carbohydrate formulation. This approach leverages the protective properties of non-digestible carbohydrates, such as inulin, resistant starch, and pectin, to encapsulate the probiotic cells. The encapsulation process involves techniques like spray drying, freeze-drying, and extrusion, which help in forming a protective matrix around the probiotic cells. The key contributions of this research include:

  • Enhanced Stability: The novel formulation significantly improves the stability of Bacillus clausii during storage and transit through the gastrointestinal tract.
  • Controlled Release: The non-digestible carbohydrate matrix ensures a controlled and sustained release of the probiotics in the intestines, maximizing their beneficial effects.
  • Improved Efficacy: The formulation enhances the colonization and activity of Bacillus clausii in the gut, leading to better health outcomes for the host.

🏆Accolades and Recognition :

The groundbreaking work on the microencapsulation and controlled release of Bacillus clausii has garnered significant accolades and recognition in the scientific community. Researchers involved in this project have been awarded prestigious grants and honors for their innovative contributions to probiotic delivery systems. Notable achievements include:

  • Best Research Paper Award: The research paper detailing the novel formulation received the best research paper award at several international microbiology and biotechnology conferences.
  • Patent Grants: Multiple patents have been granted for the unique encapsulation techniques and formulations developed during the course of this research.
  • Industry Collaborations: Leading biotechnology and pharmaceutical companies have recognized the potential of this technology and established collaborations to commercialize the probiotic delivery systems.

🌍Impact and Influence :

The impact and influence of this research extend beyond academic circles, affecting various sectors including healthcare, nutrition, and the food industry. The novel non-digestible carbohydrate formulation has revolutionized probiotic delivery, leading to:

  • Improved Gut Health: The enhanced delivery system ensures that Bacillus clausii effectively colonizes the gut, contributing to improved digestive health, immune function, and overall well-being.
  • Commercial Products: Several probiotic supplements and functional foods incorporating this technology have been successfully launched in the market, providing consumers with more effective probiotic solutions.
  • Research Advancements: The success of this research has inspired further studies into microencapsulation and controlled release technologies for other probiotic strains and bioactive compounds.

🌟Legacy and Future Contributions :

The legacy of this research lies in its transformative approach to probiotic delivery, setting a new standard for efficacy and stability in the field. Future contributions are poised to expand on this foundation, exploring:

  • Personalized Probiotic Therapies: Tailoring probiotic formulations to individual microbiome profiles for personalized health benefits.
  • Multi-Strain Encapsulation: Developing encapsulation techniques for multiple probiotic strains to create synergistic effects and enhance gut health.

🎓Publication 

Food waste leachate valorization for sustainable biomass production from Arthrospira maxima

Microencapsulation and controlled release of Bacillus clausii through a novel non-digestible carbohydrate formulation as revolutionizing probiotic delivery

    • Authors :Ramirez-Olea, H., Herrera-Cruz, S., Chavez-Santoscoy, R.A.
    • Journal   :Heliyon
    • Year       : 2024

Microencapsulation and controlled release of Bacillus clausii through a novel non-digestible carbohydrate formulation as revolutionizing probiotic delivery

  • Authors  :Ramirez-Olea, H., Herrera-Cruz, S., Chavez-Santoscoy, R.A.
  • Journal    :Heliyon
  • Year         :  2024

Synthesis and evaluation of Maillard conjugates for encapsulation and controlled delivery of quercetin under simulated gastrointestinal tract conditions

 

Essential-Oils-Loaded Biopolymeric Nanoparticles as Strategies for Microbial and Biofilm Control: A Current Status

Prof Dr. ASHOK KUMAR SHAKYA |Drug Discovery and Development| Best Researcher Award-1226

Published on by Top Pharmaceutical

Prof Dr. ASHOK KUMAR SHAKYA ,Drug Discovery and Development ,Best Researcher Award

Prof Dr. ASHOK KUMAR SHAKYA, at AL-AHLIYYA AMMAN UNIVERSITY ,Jordan

 Profile

Google scholar

    

🎓Early Academic Pursuits

Prof. Dr. Ashok K. Shakya’s academic journey began at Dr. Harisingh Gour University, Sagar (A Central University), India. He earned his Bachelor of Science in 1986, followed by a Master of Pharm. Science in 1988. His academic excellence continued as he pursued a Ph.D. in Pharmaceutical Sciences, which he completed in 1992. His doctoral research focused on the “Synthesis and Pharmacological Evaluation of Some 1:3:4 Thiadiazole Derivatives,” where he synthesized various thiadiazole derivatives and evaluated their pharmacological activities, including CNS depressant, anti-inflammatory, hypotensive, and diuretic effects.

Professional Endeavors

Dr. Shakya’s professional career spans over three decades, marked by significant contributions to pharmaceutical education and research. He began his teaching career as an Assistant Professor at Dr. Harisingh Gour University in 1988. He later held positions at Integral University, Lucknow, India, where he served as the Head of the Faculty of Pharmacy and contributed to establishing Master’s and Ph.D. programs.

In 1995, Dr. Shakya joined Ranbaxy Research Laboratories as a Manager in the Division of Clinical Pharmacology, Pharmacokinetics & Drug Metabolism. Here, he developed and validated various analytical methods for new and existing drug molecules, playing a crucial role in clinical studies (PK/BE/BA).

Since 2008, Dr. Shakya has been associated with Al-Ahliyya Amman University, Jordan. He served as an Assistant Professor, Associate Professor, and currently as a Professor in the Faculty of Pharmacy. He has been instrumental in teaching, research, and curriculum development. His administrative roles include Vice Dean of University Scientific Research and Assistant Dean of PDRC, where he established state-of-the-art research facilities and promoted research collaborations.

Contributions and Research Focus

Dr. Shakya’s research expertise encompasses Medicinal Chemistry, Pharmaceutical Analysis, Phytopharmaceuticals, Formulation Development, and Peptide Synthesis. He has developed several analytical and bioanalytical techniques for new chemical entities (NCE), investigational new drugs (IND), and abbreviated new drug applications (ANDA). His contributions include establishing GLP-compliant animal houses and staying abreast of current trends in cGMP, cGCP, and Good Laboratory Practices.

Dr. Shakya has filed two patents on anticancer and antitubercular agents. His skills extend to various analytical techniques, including LCMSMS, GC-MSMS, UPLC, and molecular modeling. He has also synthesized peptides and peptidomimetics, contributing to the field of drug design and discovery.

Accolades and Recognition

Dr. Shakya’s work has been recognized at numerous international conferences. He has presented his research at prestigious events such as the Eurasia Pharmacy Conference in Turkey, the International Conference on New Trends in Chemometrics and Applications in Turkey, and the Propolis-Human and Bee Health Conference in Bulgaria. His keynote address at the Best Med Grape conference in Beirut, Lebanon, highlights his standing in the scientific community.

Impact and Influence

As an educator and mentor, Dr. Shakya has guided over 70 master’s students, enhancing their research skills and helping them achieve their academic goals. His influence extends beyond teaching, as he has been involved in grant proposal writing, technical report authoring, and the procurement of sophisticated scientific equipment.

Dr. Shakya’s administrative roles have significantly impacted the research environment at Al-Ahliyya Amman University. He has promoted a culture of continuous quality management, encouraging faculty to publish in high-impact journals and facilitating research collaborations. His efforts have contributed to the university’s improved QS ranking and scientific reputation.

Legacy and Future Contributions

Dr. Shakya’s legacy lies in his unwavering commitment to advancing pharmaceutical sciences. His work in developing new analytical methods, synthesizing bioactive compounds, and mentoring future scientists has left an indelible mark on the field. As he continues his academic and research endeavors, Dr. Shakya remains dedicated to pushing the boundaries of pharmaceutical research and education.

🎓Publication 

Antioxidant activity of some common plants

  • Authors   :Nooman A Khalaf, Ashok K Shakya, A. Al-Othman, Zaha El-Agbar
  • Journal    :Turk J. Biol.
  • Year         : 2008

Orotransmucosal drug delivery systems: a review

    • Authors :NV Satheesh Madhav, Ashok K Shakya, Pragati Shakya, Kuldeep Singh
    • Journal   :Journal of controlled release
    • Year       : 2009

Palatal mucosa as a route for systemic drug delivery: A review

  • Authors  :Pragati Shakya, NV Satheesh Madhav, Ashok K Shakya, Kuldeep Singh
  • Journal    :Journal of controlled release
  • Year         :  2011

Fatty acids analysis, antioxidant and biological activity of fixed oil of Annona muricata L. seeds

  • Authors  :Z. Elagbar, R.R. Naik, Ashok K. Shakya, Sanaa K. Bardaweel
  • Journal   :Journal of Chemistry
  • Year        :   2016

 

Estimation of gallic acid, rutin and quercetin in Terminalia chebula by HPTLC

  • Authors  :Ashok Kumar, K Lakshman, KN Jayaveera, S Mani Tripathi, KV Satish
  • Journal   : Jordan J Pharm Sci
  • Year        :   2010

Assoc Prof Dr. Djalila Boudemagh| Pharmaceutical Chemistry| Best Researcher Award-1220

Published on by Top Pharmaceutical

Assoc Prof Dr. Djalila Boudemagh,Pharmaceutical Chemistry ,Best Researcher Award

Assoc Prof Dr. Djalila Boudemagh, at Ferhat Abbas University Setif 1, Algeria

 Profile

Scopus

    

🎓Early Academic Pursuits :

Djalila Boudemagh was born on October 31, 1973, in Constantine, Algeria. Her academic journey began at the University of Mentouri Brothers Constantine 1, where she earned her Bachelor of Science (BSc) in Chemistry in 1994. She continued her studies at the same institution, receiving her Master of Science (MSc) in Material Chemistry in 2000. Her master’s thesis focused on the effect of temperature on aluminum hydroxide, magnesium hydrogen phosphate, and their mixtures. Djalila’s passion for chemistry led her to pursue a Ph.D. in material physics at Joseph Fourier University in Grenoble, France. She completed her dissertation on the synthesis and study of thermoelectric materials of the Mg2Si1-xSnx system, earning her doctorate in 2010.

🏢Professional Endeavors :

Djalila Boudemagh has dedicated over two decades to academia and research. She began her teaching career as a temporary teacher at the Chemistry Department of the University of Mentouri Brothers Constantine 1 in 1998 and later taught in the Medicine and Biology Departments until 2000. In November 2001, she joined the Department of Process Engineering at Ferhat Abbas University of Setif -1, Algeria, as an Assistant Professor. After twelve years of dedicated teaching and research, she was promoted to Associate Professor in July 2013.

In addition to her academic role, Djalila provides training and consulting services in the field of intellectual and industrial property. She has extensive experience in tutoring A-level students in various subjects, including biophysics, chemistry, the elaboration and characterization of nanoparticles, spectroscopic analysis of surfaces, and the physicochemical structure of biological macromolecules.

🔬Contributions and Research Focus :

Djalila’s research interests span a wide range of topics in chemistry and material science. Her work primarily focuses on the synthesis and application of materials and nanomaterials for health and environmental purposes, including adsorption and photocatalysis. She has made significant contributions to the field of biomaterials and composites, particularly in polymers and mineral fillers, and the extraction and isolation of bioactive molecules from plants. Her research also extends to pharmaceutical technology, water treatment, crystallization, and the development of thin films using PAPVD methods.

She has successfully supervised five Ph.D. students and twelve MSc students, guiding them through various projects related to her research interests. Djalila’s expertise in the development of nanoparticles and nanocomposites, as well as her proficiency in techniques such as sol-gel and hydrothermal methods, have established her as a prominent figure in her field.

🏅Accolades and Recognition :

In October 2019, Djalila received accreditation to direct research (HDR in Chemistry) from the Department of Chemistry at Ferhat Abbas University, Setif. This significant achievement highlights her expertise and leadership in the field of chemistry. Her research has been recognized and supported through various funded projects, including ongoing initiatives at Ferhat Abbas University Setif-1, focusing on the development of new biomaterials for tissue regeneration and environmental applications.

🌍Impact and Influence :

Djalila Boudemagh’s work has had a profound impact on both the academic and industrial sectors. Her consulting services in product development and intellectual property have benefited numerous companies, and her training programs have equipped professionals with essential skills in industrial and intellectual property. Her participation in various national and international exhibitions and fairs, such as the SIPSA FILAHA & AGROFOOD and the National Agriculture Exhibition “Mosta Expo,” showcases her commitment to sharing knowledge and fostering innovation.

🌟Legacy and Future Contributions :

Djalila Boudemagh’s legacy lies in her dedication to education, research, and the advancement of science. Her contributions to the synthesis and application of materials and nanomaterials have paved the way for future innovations in health and environmental technologies. As a member of the Mediterranean Network Act for Health and the CATI “Technology and Innovation Support Center” at Ferhat Abbas University Setif 1, she continues to collaborate with international experts and institutions, driving forward research and development in her field.

🎓Publication 

Quantification, phytochemical evaluation, and identification of pomegranate yellow peel constituents using LC-MS/MS, the effect of the solvent extract on the antioxidant, in vitro anti-inflammatory, and antibacterial activities

Elaboration of hydroxyapatite nanoparticles and chitosan/hydroxyapatite composites: a present status

Isolation, characterization, antioxidant activity, and protein-precipitating capacity of the hydrolyzable tannin punicalagin from pomegranate yellow peel (Punica granatum)

Crystal structure analysis of the Mg2Si1-xSn x system having potential thermoelectric properties at high temperature

  • Authors  :Boudemagh, D., Fruchart, D., Haettel, R., … Toboła, J., Wolfers, P.z
  • Journal   :Solid State Phenomena
  • Year        :   2011

 

 

Dr.Alice Bejjan| Pharmaceutical Analysis| Women Researcher Award

Published on by Top Pharmaceutical

Dr.Alice Bejjan,Pharmaceutical Analysis ,Women Researcher Award

Dr.Alice Bejjan, at ational Council for Scientific Research of Lebanon-Lebanese Atomic Energy Commission, Lebanon

 Profiles

Scopus

Google scholar         

Orcid

🎓Early Academic Pursuits :

Alice Bejjani’s journey into the world of physics began with a solid academic foundation. She pursued her undergraduate studies at the Lebanese University, Department of Physics and Electronics in Fanar, Lebanon, where she earned her Maitrise in Physics with high distinction in 2003. Her passion for materials science and electronic components led her to continue her studies at the Lebanese University, Faculty of Sciences. There, she obtained a Master of Advanced Studies (DEA) in 2004, once again graduating with high distinction. Alice’s academic pursuits culminated in a Ph.D. in Physics from the Claude Bernard University of Lyon, Institute of Nuclear Physics, France, in 2009, where she achieved the highest honors.

🏢Professional Endeavors :

Alice’s professional career is marked by her extensive contributions to the Lebanese Atomic Energy Commission-National Council for Scientific Research (LAEC-NCSR). She began her journey as a part-time research assistant at the Accelerator Laboratory of LAEC-NCSR in 2004-2005. Following her Ph.D., she returned to LAEC-NCSR as a part-time researcher, equivalent to a post-doctoral position, from 2010 to 2014. During this time, she played a pivotal role in establishing the first research laboratory in the MENA region for surface, chemical, and structural analysis of solid materials using the Time of Flight Secondary Ion Mass Spectrometry (TOF-SIMS) technique.

In 2014, Alice was appointed as a full-time researcher at LAEC-NCSR, a position she held until 2019. Her research interests include exploring novel applications, developing innovative protocols, and combining ion beam technology with optical spectroscopic and chromatography methods to examine materials pertinent to health, environmental studies, and forensic sciences. Since 2019, she has been serving as a senior researcher, furthering her contributions to the field.

🔬Contributions and Research Focus :

Alice’s research has had a profound impact on the fields of health, environmental studies, and forensic sciences. As the coordinator of the Forensic Research Program at LAEC-NCSR since 2016, she has fostered synergy among her fellow researchers to achieve program objectives. She has designed and implemented Memorandums of Understanding (MOUs) with partners, driving impactful advancements in forensic research.

As the principal investigator of the TOF-SIMS laboratory, Alice oversees a team of researchers, research assistants, and master’s/Ph.D. students. She has established and enforced standard operating protocols to ensure compliance with safety and regulatory guidelines, maintained the laboratory’s cutting-edge status through equipment procurement and technology advancements, and implemented preventive maintenance plans to ensure optimal functionality and efficiency. Her efforts have also included fostering collaborations with local and international universities and research centers.

 🏆Accolades and Recognition :

Alice’s dedication and contributions to science have been recognized through various national and international grants. Notable among these are:

  1. TC-IAEA Grant (2022-2025): €405,000 for strengthening forensic needs in material investigation.
  2. NCSR National Grant (2018-2019): $19,000 for multi-dimensional analysis of new functional polymers.
  3. NCR Italy-NCSR Mobility Grant (2017-2019): €8,000 for safeguarding saffron authenticity using innovative mass spectrometry.
  4. TC-IAEA Grant (2015-2018): €350,000 for enhancing forensic science capabilities.
  5. TC-IAEA Grant (2012-2014): €350,000 for upgrading surface, elemental, and structural analysis capabilities.
  6. TC-IAEA Grant (2010-2012): €522,000 for enhancing the LAEC’s analytical capabilities.

🌟Impact and Influence :

Alice’s work has had a significant impact on the scientific community and beyond. Her research has contributed to advancements in forensic science, health, and environmental studies. By developing innovative protocols and combining ion beam technology with other analytical methods, she has opened new avenues for material analysis. Her leadership in establishing and maintaining the TOF-SIMS laboratory has provided valuable resources for researchers in the MENA region and internationally.

🌍Legacy and Future Contributions :

Alice Bejjani’s legacy is one of dedication, innovation, and collaboration. Her contributions to the scientific community, particularly in the fields of forensic science and material analysis, have set a high standard for future researchers. As she continues her work at LAEC-NCSR, she is poised to make further advancements in her field, fostering interdisciplinary collaboration and driving impactful research. Her commitment to mentoring the next generation of scientists ensures that her influence will continue to be felt for years to come. Alice’s journey is a testament to the power of perseverance, passion, and the pursuit of excellence in science.

🎓Publication 

Fe0-based trimetallic systems for the removal of aqueous diclofenac: Mechanism and kinetics

  • Authors   :Antoine Ghauch, Hala Abou Assi, Habib Baydoun, Al Muthanna Tuqan, Alice Bejjani
  • Journal    :Chemical Engineering Journal
  • Year         : 2011

Iron-based metal organic framework MIL-88-A for the degradation of naproxen in water through persulfate activation

    • Authors : Rime El Asmar, Abbas Baalbaki, Zahraa Abou Khalil, Sahar Naim, Alice Bejjani, Antoine Ghauch
    • Journal   :Chemical Engineering Journal
    • Year       : 2011
Toward cell selective surfaces: cell adhesion and proliferation on breath figures with antifouling surface chemistry
  • Authors  : Enrique Martínez-Campos, Tamara Elzein, Alice Bejjani, Maria Jesús García-Granda, Ana Santos-Coquillat, Viviana Ramos, Alexandra Muñoz-Bonilla, Juan Rodríguez-Hernández
  • Journal    :ACS Applied Materials & Interfaces
  • Year         :  2016
Hydrophobization of chitosan films by surface grafting with fluorinated polymer brushes
  • Authors  : Bénédicte Lepoittevin, Tamara Elzein, Diana Dragoe, Alice Bejjani, Frédéric Lemée, Jocelyne Levillain, Philippe Bazin, Philippe Roger, Isabelle Dez
  • Journal   :Carbohydrate polymers
  • Year        :   2019

Surface initiated supplemental activator and reducing agent atom transfer radical polymerization (SI-SARA-ATRP) of 4-vinylpyridine on poly (ethylene terephthalate)

  • Authors  : Mohamad Maaz, Tamara Elzein, Alice Bejjani, Nadine Barroca-Aubry, Bénédicte Lepoittevin, Diana Dragoe, Sandra Mazerat, Bilal Nsouli, Philippe Roger
  • Journal   :Journal of colloid and interface science
  • Year        : 2017